Press release
Regenerative Medicine Pioneer Benito Novas Announces Sao Paulo International Summit Following Successful ISSCA Global Summit in Cancun
Global Stem Cells Group founder with 15+ years building physician networks across 30+ countries hosts October 2-3 Sao Paulo conferenceImage: https://www.abnewswire.com/upload/2025/09/3bf1a435e02bc3fef768990a0eb84d0d.jpg
SAO PAULO, Brazil - September 17, 2025 - Benito Novas, founder and CEO of Global Stem Cells Group, announces Sao Paulo, Brazil will host an international conference in Regenerative Medicine and Cellular Therapies on October 2-3, 2025, following the successful completion of the ISSCA Global Summit in Cancun on September 12-13.
Novas has built the world's most extensive physician training network in regenerative medicine since founding Global Stem Cells Group in 2010. His organization spans 30+ global cities across five continents and has trained over 6,000 medical professionals worldwide.
Established Authority in Global Medical Education
Novas's career began with co-founding medical clinics in the United States in 2005, followed by launching Aesthetic Marketing Group in 2008. He founded Global Stem Cells Group in 2010, transforming it into a key international player with partners in over 30 cities by 2017.
His contributions to advancing regenerative medicine earned him Doctor Honoris Causa in Health Sciences in Medellin, Colombia in 2019. In 2022, he organized the ISSCA World Congress in Istanbul, bringing together physicians from 35+ countries.
Recent Global Expansion
Recent network developments include new affiliate partnerships in Northern Argentina, Paraguay, and Puerto Rico. Additional expansion includes strategic collaboration with Njinsky Medical Centre to launch CELLGENIC exosome therapies in Pakistan. The recent ISSCA Buenos Aires event and September 12-13 Cancun Global Summit drew hundreds of physicians, establishing momentum for the larger Sao Paulo gathering.
Sao Paulo Conference Registration
The October 2-3 Sao Paulo conference features international faculty presenting developments in regenerative medicine education. Healthcare professionals can register through the ISSCA platform.
About Benito Novas and Global Stem Cells Group
Benito Novas is founder and CEO of Global Stem Cells Group, establishing the world's largest physician training network in regenerative medicine. Since 2010, he has trained over 6,000 medical professionals across 30+ global cities spanning five continents. The International Society for Stem Cell Application (ISSCA) serves as the educational division, providing comprehensive training programs and clinical protocols.
Media Contact
Company Name: ISSCA & Global Stem Cells Group
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=regenerative-medicine-pioneer-benito-novas-announces-so-paulo-international-summit-following-successful-issca-global-summit-in-cancun]
Phone: +1 (713) 570-6106
Country: Brazil
Website: https://benitonovas.com
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Regenerative Medicine Pioneer Benito Novas Announces Sao Paulo International Summit Following Successful ISSCA Global Summit in Cancun here
News-ID: 4187125 • Views: …
More Releases from ABNewswire
Genloop Meets Prime Minister Narendra Modi to Advance Vision for Ethical, Scalab …
Genloop leaders met with India's Prime Minister to discuss advancing ethical, scalable AI from innovation to real-world deployment.
Santa Monica, CA - January 14, 2026 - Genloop [https://genloop.ai/?utm_source=ABNews&utm_medium=email&utm_campaign=1752vc], a portfolio company of 1752vc [http://1752.vc/?utm_source=abnews] (formerly Pegasus Angel Accelerator), announced that its leadership met with the Prime Minister of India, Narendra Modi, at his official residence, 7 Lok Kalyan Marg, for a high-level strategic discussion on the future of artificial intelligence in…
Alopecia Areata Market to Witness Promising Upswing by 2034, DelveInsight Foreca …
The Key Alopecia Areata Companies in the market include - Eli Lilly and Company/Incyte Corporation, Pfizer, Legacy Healthcare, Pfizer, Q32 Bio Inc., AbbVie, Amgen, Concert Pharmaceuticals, Bristol-Myers Squibb, Reistone Biopharma, Inmagene LLC, Suzhou Zelgen Biopharma, Nektar Therapeutics, AnaptysBio, Inc., LEO Pharma, Eli Lilly and Company, and others.
The Alopecia Areata market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage…
Neko Case Neon Grey Midnight Green 2026: Affordable Tickets + CITY10 Code for In …
Neko Case's Neon Grey Midnight Green Tour rocks North America in 2026, celebrating her acclaimed Sept 2025 album-first new solo work since 2018-with raw, live-recorded tracks, powerful vocals, and hits like "Hold On, Hold On." Catch her with Des Demonas (East/Midwest) or Destroyer (West) from Jan 8 Montreal to March dates in CO, CA & more!
Neko Case [https://www.capitalcitytickets.com/Neko-Case-Tickets] is embarking on her electrifying Neon Grey Midnight Green Tour in 2026,…
Toogood Gold Expands Footprint, Positioned for High-Impact Growth 2026 Alongside …
Toogood Gold Corp. (TSXV: TGC | OTCQB: TGGCF) reported final drilling assays from its 100%-owned Toogood Gold Project in Newfoundland, delivering results that significantly expand the scale, continuity, and upside potential of its gold discovery heading into 2026.
The Company's 2025 drill program confirmed the Quinlan target as a large, coherent gold system, with gold intersected in all 30 drill holes completed to date. High-grade intervals and visible gold were reported…
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copy…
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
